Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Ann Trop Med Parasitol ; 105(1): 1-11, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21294944

ABSTRACT

Hendra virus (HeV) was first isolated in 1994, from a disease outbreak involving at least 21 horses and two humans in the Brisbane suburb of Hendra, Australia. The affected horses and humans all developed a severe but unidentified respiratory disease that resulted in the deaths of one of the human cases and the deaths or putting down of 14 of the horses. The virus, isolated by culture from a horse and the kidney of the fatal human case, was initially characterised as a new member of the genus Morbillivirus in the family Paramyxoviridae. Comparative sequence analysis of part of the matrix protein gene of the virus and the discovery that the virus had an exceptionally large genome subsequently led to HeV being assigned to a new genus, Henipavirus, along with Nipah virus (a newly emergent virus in pigs). The regular outbreaks of HeV-related disease that have occurred in Australia since 1994 have all been characterised by acute respiratory and neurological manifestations, with high levels of morbidity and mortality in the affected horses and humans. The modes of transmission of HeV remain largely unknown. Although fruit bats have been identified as natural hosts of the virus, direct bat-horse, bat-human or human-human transmission has not been reported. Human infection can occur via exposure to infectious urine, saliva or nasopharyngeal fluid from horses. The treatment options and efficacy are very limited and no vaccine exists. Reports on the outbreaks of HeV in Australia are collated in this review and the available data on the biology, transmission and detection of the pathogen are summarized and discussed.


Subject(s)
Chiroptera/virology , Disease Outbreaks , Hendra Virus/pathogenicity , Henipavirus Infections/epidemiology , Henipavirus Infections/virology , Horse Diseases/virology , Animals , Australia/epidemiology , Disease Outbreaks/statistics & numerical data , Hendra Virus/genetics , Hendra Virus/isolation & purification , Henipavirus Infections/mortality , Henipavirus Infections/transmission , Horse Diseases/epidemiology , Horse Diseases/transmission , Horses , Humans , Immunohistochemistry , Nipah Virus/pathogenicity , Zoonoses/epidemiology , Zoonoses/virology
2.
Ann Trop Med Parasitol ; 104(8): 613-21, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21144181

ABSTRACT

Since its discovery in a juvenile black flying fox (Pteropus alecto) in 1996, Australian bat lyssavirus (ABLV) has become the cause of a potentially important emerging disease for health authorities in Australia, with two human deaths (one in 1996 and one in 1998) attributed to the virus in the north-eastern state of Queensland. In Australia, the virus has been isolated from all four species of flying fox found on the mainland (i.e. P. alecto, P. scapulatus, P. poliocephalus and P. conspicillatus) as well as a single species of insectivorous bat (Saccolaimus flaviventris). Australian bat lyssavirus belongs to the Lyssavirus genus and is closely related, genetically, to the type strain of Rabies virus (RABV). Clinically, patients infected with ABLV have displayed the 'classical' symptoms of rabies and a similar disease course. This similarity has led to the belief that the infection and dissemination of ABLV in the body follows the same pathways as those followed by RABV. Following the two ABLV-related deaths in Queensland, protocols based on the World Health Organization's guidelines for RABV prophylaxis were implemented and, presumably in consequence, no human infection with ABLV has been recorded since 1998. ABLV will, however, probably always have an important part to play in the health of Australians as the density of the human population in Australia and, consequently, the level of interaction between humans and flying foxes increase.


Subject(s)
Chiroptera/virology , Lyssavirus/isolation & purification , Rabies Vaccines/administration & dosage , Rhabdoviridae Infections/virology , Animals , Australia/epidemiology , Bites and Stings , Guidelines as Topic , Humans , Lyssavirus/classification , Phylogeny , Post-Exposure Prophylaxis/methods , Rhabdoviridae Infections/transmission , Risk Factors , World Health Organization
3.
Br J Hosp Med (Lond) ; 69(1): 8-12, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18293721

ABSTRACT

Acute heart failure and cardiogenic shock are medical emergencies requiring urgent medical intervention. This article defines each syndrome and reviews the latest evidence regarding their clinical presentation, management and prognosis.


Subject(s)
Cardiology Service, Hospital , Heart Failure/therapy , Shock, Cardiogenic/therapy , Acute Disease , Chronic Disease , Echocardiography/methods , Heart Failure/diagnostic imaging , Heart Failure/etiology , Humans , Prognosis , Shock, Cardiogenic/diagnostic imaging , Shock, Cardiogenic/etiology
4.
Kidney Int ; 58(4): 1440-9, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11012879

ABSTRACT

BACKGROUND: Resistance to the action of parathyroid hormone (PTH) has been demonstrated in end-stage renal failure and is considered to be important in the pathogenesis of secondary hyperparathyroidism. The mechanism of resistance is unknown. However, altered regulation of cellular PTH/PTH-related protein (PTH/PTHrP) receptor (PTH1R) has been assumed to be important. METHODS: We have used in situ hybridization to examine PTH1R mRNA expression by osteoblasts in human bone and have compared the expression in high- and low-turnover renal bone disease, high-turnover nonrenal bone disease (healing fracture callus and Pagetic bone), and normal bone. Bone biopsies were formalin fixed, ethylenediaminetetraacetic acid decalcified, and paraffin wax embedded. A 1.8 kb PTH1R cDNA probe, labeled with 35S, was used, and the hybridization signal was revealed by autoradiography. The density of signal over osteoblasts was quantitated using a semiautomated Leica image analysis software package. RESULTS: The mean density of PTH1R mRNA signal over osteoblasts in renal high-turnover bone was only 36% of that found in nonrenal high-turnover bone (P < 0.05) and 51% of that found in normal bone (P < 0.05). Osteoblast PTH1R mRNA signal in adynamic bone from individuals with diabetes mellitus was 28% of normal bone (P < 0.05) and 54% of that found in renal high-turnover bone (P < 0.05). CONCLUSIONS: These results demonstrate a down-regulation of osteoblast PTH1R mRNA in end-stage renal failure in comparison to normal and high-turnover bone from otherwise healthy individuals, and provide an insight into the mechanisms of "skeletal resistance" to the actions of PTH.


Subject(s)
Kidney Failure, Chronic/metabolism , Kidney Failure, Chronic/physiopathology , Osteoblasts/metabolism , Receptors, Parathyroid Hormone/genetics , Adult , Bone and Bones/metabolism , Bony Callus/metabolism , Bony Callus/physiopathology , Chronic Kidney Disease-Mineral and Bone Disorder/metabolism , Chronic Kidney Disease-Mineral and Bone Disorder/physiopathology , Diabetic Nephropathies/metabolism , Diabetic Nephropathies/physiopathology , Down-Regulation/genetics , Female , Gene Expression/physiology , Humans , In Situ Hybridization , Male , Middle Aged , Osteitis Deformans/metabolism , Osteitis Deformans/physiopathology , Osteoclasts/metabolism , RNA, Messenger/metabolism , Receptor, Parathyroid Hormone, Type 1 , Receptors, Parathyroid Hormone/metabolism , Uremia/metabolism , Uremia/physiopathology
10.
J Nucl Med ; 16(2): 151-5, 1975 Feb.
Article in English | MEDLINE | ID: mdl-1110421

ABSTRACT

Thallium-201 merits evaluation for myocardial visualization, kidney studies, and tumor diagnosis because of its physical and biologic properties. A method is described for preparation of this radiopharmaceutical for human use. A critical evaluation of 201Tl and other radiopharmaceuticals for myocardial visualization is given.


Subject(s)
Myocardial Infarction/diagnosis , Radionuclide Imaging , Thallium , Cesium Isotopes , Potassium Isotopes , Quality Control , Radioisotopes
11.
J Nucl Med ; 16(2): 156-60, 1975 Feb.
Article in English | MEDLINE | ID: mdl-1110422

ABSTRACT

Thallium-201 has been evaluated for myocardial imaging by determining its distribution and assessing its imaging properties. Organ distribution with time was studied in goats, chosen for their large size and easy operability. Myocardial imaging was performed in living and sacrificed goats and also in two anesthetized dogs, without infarction. Infarcts were made by ligature at open chest surgery on the goats and the infarcts subsequently confirmed histologically. The myocardium of normal and infarced, young and old goats was cut into blocks and the isotope distribution measured and compared with that in the lungs, liver, spleen, and kidney in normal goats. The renal medulla-to-cortex concentration ratio in goats was studied and is approximately five. The heart uptake exceeds 3% for 100 min whereas contiguous organs have less than one-half of the myocardial concentration, and blood clearance is rapid. One problem may prove to be inhomogeneity of uptake of thallium in the "normal" myocardium, showing a standard deviation of 1u% in a young goat and 29% in an old goat. In view of the good myocardial uptake, however, this work strongly suggests the trial 201Tl in patients.


Subject(s)
Myocardial Infarction/diagnosis , Radionuclide Imaging , Thallium , Animals , Diaphragm/metabolism , Dogs , Goats , Kidney/metabolism , Kidney Cortex/metabolism , Kidney Medulla/metabolism , Liver/metabolism , Lung/metabolism , Muscles/metabolism , Myocardium/metabolism , Rabbits , Radiation Dosage , Radioisotopes , Spleen/metabolism , Thallium/blood , Thallium/metabolism , Thallium/toxicity , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...